Latest Schedule 13G passive stakes

Michal Adam Karminski has significantly reduced his beneficial ownership in Grayscale Near Trust from over 5% to 2.61%, as reported in a Schedule 13G filing.

Acorn Bioventures and related entities have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a combined stake of 5.7%.

Michal Adam Karminski has reported beneficial ownership of 680,019 shares, representing 8.44% of The Zcash ETF.

Acorn Bioventures, L.P., along with affiliated entities and individual Anders Hove, have reported beneficial ownership of 5.7% of Karyopharm Therapeutics Inc. common stock.

Yip Wai Lun has filed a Schedule 13G, reporting beneficial ownership of 208,334 shares, representing 9.90% of Addentax Group Corp.'s common stock.

Dani Reiss and DTR LLC report increased beneficial ownership and voting power in Canada Goose Holdings Inc. Subordinate Voting Shares.

Joshua Mailman has filed a Schedule 13G, disclosing beneficial ownership of 189,617 shares, representing 9.99% of Jaguar Health, Inc.'s common stock.

Alexander Monje and Biscayne Ventures LLC report beneficial ownership of 8.6% of Host Digital Inc.'s Class A common stock.

This filing details an amendment to Schedule 13G for Xanadu Quantum Technologies Ltd., clarifying beneficial ownership of Class B Subordinate Voting Shares.

Jane Street Group, LLC, Jane Street Capital, LLC, and Jane Street Global Trading, LLC have collectively reported beneficial ownership of 5.0% of IP Strategy Holdings, Inc. common stock.

New Enterprise Associates entities and associated individuals have filed a joint Schedule 13G, reporting beneficial ownership of Coursera, Inc. common stock.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 2,685,520 shares, representing 5.49% of BioLife Solutions, Inc.'s common stock.

Manchester Management entities and individuals James E. Besser and Morgan C. Frank have collectively reported beneficial ownership of 7.4% of Alpha Cognition Inc.'s common stock.

SCWorx Corp. has filed a Schedule 13G detailing beneficial ownership changes, with Intracoastal Capital LLC, Mitchell P. Kopin, and Daniel B. Asher collectively holding 9.1% of common stock.

Perceptive Advisors LLC, along with affiliated entities and Joseph Edelman, has reported beneficial ownership of 5.3% of Nurix Therapeutics, Inc. common stock.

Hawk Ridge Capital Management LP and its affiliates have reported beneficial ownership of 5.1% of Array Digital Infrastructure, Inc.'s common shares, totaling 2,728,548 shares.

Tejara Capital Limited, through its managed fund Trefoil Select Funds SPC-Stylus SP, has reported beneficial ownership of 6,382,551 Class A Common Shares, representing 5.3% of the outstanding shares in Cardiol Therapeutics Inc.

Atlas Infrastructure Partners (UK) Ltd. and GIP Atlas Holdings Limited have filed an amendment to their Schedule 13G, correcting a previous misclassification of filing rule.

Several entities affiliated with Millennium Management have filed a Schedule 13G to confirm their beneficial ownership of Better Home & Finance Holding Company's Class A Common Stock.

RA Capital Management and its affiliates have reported beneficial ownership of 9.0% of BetterLife Pharma Inc.'s common shares, signaling a substantial investment.

RainForest Partners LLC has disclosed beneficial ownership of 2,298,851 shares, representing 8.404% of Cyabra, Inc.'s common stock, as of September 22, 2026.

The Hewlett Fund LP has reported beneficial ownership of 2,271,051 shares, representing 8.3% of Cyabra Inc.'s common stock, as of September 8, 2026.

PharmAla Biotech Holdings Inc. has disclosed beneficial ownership of 17.3% of Jupiter Neurosciences, Inc. common stock.

Leviticus Partners LP has filed a Schedule 13G, revealing beneficial ownership of 235,000 shares, representing 5.2% of Harvard Bioscience Inc.'s common stock.

ARC Group Limited and Abraham Cinta have jointly filed a Schedule 13G, reporting beneficial ownership of 2,739,152 ordinary shares, representing 18.26% of Black Titan Corp.

A Schedule 13G filing reveals updated beneficial ownership details for Advanced Biomed Inc. common stock.

Several Venrock-affiliated entities and individuals have jointly filed a Schedule 13G, reporting beneficial ownership of 5.6% of X4 Pharmaceuticals, Inc. common stock.

Several entities and an individual have entered into a joint filing agreement to disclose beneficial ownership of MarineMax Inc. common stock.

Thrivent Financial for Lutherans has reported beneficial ownership of 740,000 shares, representing 24.7% of the Mandatory Redeemable Preferred Shares, Series B, of RiverNorth Opportunities Fund, Inc.

Several Biotechnology Value Funds and Mark N. Lampert have filed a joint statement detailing their beneficial ownership of Tyra Biosciences, Inc. common stock.